Moreover, CCL5 chemokine expression has been correlated with advanced breast cancer in human patients [42] and was reported to promote mammary tumor growth in mice, whereas the deficiency of this chemokine resulted in the aberrant generation of MDSCs in the bone marrow, with the impaired immunosuppressive ability [43]. This evidence concerns the gene CCL5 and breast cancer.